Director
AstraZeneca
Gaithersburg, Maryland
Dr. Lin Yang, Director and Team Lead, Integrated Bioanalysis at AstraZeneca (Gaithersburg, MD), is an experienced bioanalytical science leader with more than 20 years of experience across AstraZeneca, REGENXBIO, and Covance/LabCorp. Her work focuses on developing and validating advanced bioanalytical methods to support drug discovery and clinical development, ensuring rigorous GxP compliance and contributing to regulatory submissions. Dr. Yang has authored numerous high-impact publications and white papers and actively contributes to industry forums, helping shape best practices across the bioanalytical community. She holds a PhD in Biochemistry from East Tennessee State University and an MS in Chemistry from Wuhan University.
Disclosure information not submitted.
From Artifacts to Insight: Antidrug Antibody Assays for Antibody-drug Conjugates
Tuesday, July 14, 2026
8:35 AM - 9:05 AM East Coast USA Time
Tuesday, July 14, 2026
11:00 AM - 11:30 AM East Coast USA Time